Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

High-Throughput Screening Services

NCI-60

Researchers can request to submit compounds to the high-throughput NCI-60 Human Tumor Cell Line Screen.  It is a free and unique screen across 60 standard human tumor cell lines to measure their anti-cancer activity. The COMPARE tool enables response patterns to be analyzed and identification of other compounds with similar profiles.

Patient-Derived Organoid Screening

NCI will soon be launching a publicly available in vitro organoid screening service in cancer histology panels that are designed to represent a diversity of subtypes based on their molecular characterization.  The organoids, as well as the matching patient-derived xenografts and cell lines, are also publicly available, along with growth conditions and SOPs, through the Patient-Derived Models Repository. 

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “High-Throughput Screening Services was originally published by the National Cancer Institute.”

Email